13.49USD0.00%Mkt Cap: 3.54B $P/E: 14.511d ago
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, …
Industry Peers
Drug Manufacturers - General$1.04TUSDP/E 41.6
$601.73BUSDP/E 29.0
$449.42BUSDP/E 124.1
$305.83BUSDP/E 21.0
$315.22BUSDP/E 36.0
$272.16BUSDP/E 21.8
$268.42BUSDP/E 21.8
$243.51BUSDP/E 25.4
$216.37BUSDP/E 12.3
$212.87BUSDP/E 25.1
$200.54BUSDP/E 25.9
$169.23BUSDP/E 18.5
$143.28BUSDP/E 19.2
$123.57BUSDP/E 16.9
$100.10BUSDP/E 19.4
$85.16BUSDP/E 13.8
$50.96BUSD
$30.84BUSDP/E 22.4
MRV
Marvell Technology, Inc.$20.08BUSDP/E 7.4
$11.37BUSDP/E 22.7
$10.53BUSDP/E 18.3
$10.47BUSDP/E 18.2
$6.76BUSDP/E 15.0
$2.97BUSDP/E 18.1
$61.82MUSD
$39.24MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FR0000140022
SANOFITP29OCT49—
CELG-RI
Bristol-Myers Squibb Company Ce—
FLXN
Horizon Flexible Income ETF—P/E 27.0
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap3.54B $
Enterprise Value11.00B $
Revenue (TTM)6.16B $
Gross Profit3.31B $
Net Income (TTM)187.00M $
Revenue/Share23.69 USD
Last Price13.49 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)14.51
P/E (Forward)3.71
PEG—
EV/EBITDA6.89
EV/Revenue1.78
P/S0.57
P/B3.92
EPS (TTM)0.93
EPS (Forward)3.64
52W Range
5.69099% of range13.60
52W High13.60 USD
52W Low5.690 USD
Profitability
Gross Margin53.30%
Oper. Margin18.70%
EBITDA Margin25.88%
Profit Margin3.01%
ROE24.87%
ROA1.45%
Growth
Revenue Growth-3.50%
Earnings Growth66.70%
Cash Flow & Leverage
Operating CF700.00M $
CapEx (TTM)316.00M $
FCF Margin8.59%
FCF Yield14.94%
Net Debt7.45B $
Net Debt/EBITDA4.67
Balance Sheet
Debt/Equity11.49
Current Ratio1.97
Quick Ratio1.00
Book Value/Sh3.438 USD
Cash/Share4.250 USD
Dividends
Fwd Div Rate0.0800 USD
Trail. Div Rate0.0800 USD
Div. Yield0.59%
5Y Avg Yield—
Payout Ratio8.60%
Ex-Div DateMay 11, 2026
Pay DateJun 11, 2026
Analyst Consensus
Rating—
Target (Mean)11.25 USD
Upside (mean)-16.6%
Target Range8.000 USD – 14.00 USD
$8.000-16.6% to mean$14.00
# Analysts4
Ownership
Shares Out.262.61M
Float261.08M
Insiders0.47%
Institutions77.78%
Short Interest
Short Ratio7.0d
Short % Float7.40%
Short % Out.6.51%
Shares Short17.09M
Short (prev mo.)18.07M
Technical
SMA 5013.43 (+0.5%)
SMA 2009.378 (+43.8%)
Beta1.54
S&P 52W Chg19.63%
Avg Vol (30d)1.84M
Avg Vol (10d)2.56M
Technical Indicators
RSI (14)62.3
MACD0.0919
MACD Signal0.1310
MACD Hist.-0.0391
BB Upper13.58 USD
BB Middle13.49 USD
BB Lower13.40 USD
BB Width1.30%
ATR (14)0.0616 USD
Vol Ratio (20d)1.16x